Federated Hermes
BCAB icon

Federated Hermes’s BioAtla BCAB Stock Holding History

Federated Hermes’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41
Closed -$703 – 2070
2025
Q1 		$703 Buy
41
+6
+17% +$128 ﹤0.01% 2012
2024
Q4 		$1.05K Hold
35
– – ﹤0.01% 2020
2024
Q3 		$3.11K Sell
35
-40
-53% -$3.35K ﹤0.01% 1906
2024
Q2 		$5.11K Buy
+75
New +$8.92K ﹤0.01% 1836
2024
Q1 		– Sell
-57
Closed -$6.96K – 2038
2023
Q4 		$6.96K Buy
57
+16
+39% +$1.39K ﹤0.01% 1822
2023
Q3 		$3.49K Buy
+41
New +$5.23K ﹤0.01% 1921

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Federated Hermes's BCAB Position: Q2 2025 in Review

Federated Hermes sold out of BioAtla (BCAB) in Q2 2025, closing a stake of 41 shares — an estimated $703 sold.

Federated Hermes first reported a position in BCAB in Q3 2023 and held it in 6 quarters. The position peaked at $6.96K in Q4 2023. 39 funds tracked by Wall St. Rank hold BCAB as of Q2 2025.

  • Federated Hermes reported no remaining BioAtla position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 41 BioAtla shares in Q2 2025, an estimated $703.
  • Federated Hermes first reported a position in BioAtla in Q3 2023 and held it in 6 quarters.
  • Federated Hermes's BioAtla position peaked at $6.96K in Q4 2023.
  • 39 funds tracked by Wall St. Rank held BioAtla as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.